UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

Annals of oncology, 2012-06, Vol.23 (6), p.1607-1616

2012

Volltextzugriff (PDF)

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer

Annals of oncology, 2006-04, Vol.17 (4), p.588-596

2006

Volltextzugriff (PDF)

Molecular subtypes of breast cancer and amplification of topoisomerase IIα : predictive role in dose intensive adjuvant chemotherapy

British journal of cancer, 2006-11, Vol.95 (10), p.1334-1341

2006

Volltextzugriff (PDF)

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences

European journal of cancer (1990), 2003-03, Vol.39 (5), p.614-621

2003

Volltextzugriff (PDF)

Response Shift in Quality of Life Measurement in Early-Stage Breast Cancer Patients Undergoing Radiotherapy

Quality of life research, 2000-01, Vol.9 (6), p.603-615

2000

Volltextzugriff (PDF)

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?

British journal of cancer, 2001-06, Vol.84 (12), p.1577-1585

2001

Volltextzugriff (PDF)

Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study

European journal of cancer (1990), 2005, Vol.41 (2), p.225-230

2005

Volltextzugriff (PDF)

Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients

Bone marrow transplantation (Basingstoke), 2008-10, Vol.42 (7), p.475-481

2008

Volltextzugriff (PDF)

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer : is treatment worthwhile?

British journal of cancer, 2001-06, Vol.84 (12), p.1577-1585

2001

Volltextzugriff (PDF)

Survival of patients with ovarian cancer due to a mismatch repair defect

Familial cancer, 2005-01, Vol.4 (4), p.301-305

2005

Volltextzugriff (PDF)

Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: A population-based study

European journal of surgical oncology, 2009-12, Vol.35 (12), p.1326-1332

2009

Volltextzugriff (PDF)

Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study

Gynecologic oncology, 2001-06, Vol.81 (3), p.348-354

2001

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

The New England journal of medicine, 2010-09, Vol.363 (10), p.943-953

2010

Volltextzugriff (PDF)

Diabetes insipidus and adrenal insufficiency in a patient with metastatic breast cancer

Netherlands journal of medicine, 2006-09, Vol.64 (8), p.310-313

2006

Volltextzugriff (PDF)

D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study

Anti-cancer drugs, 2001-02, Vol.12 (2), p.159-162

2001

Volltextzugriff (PDF)

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy

Gynecologic oncology, 2013-11, Vol.131 (2), p.437-444

2013

Volltextzugriff (PDF)

Stability of patients' preferences for chemotherapy: the impact of experience

Medical decision making, 2001-07, Vol.21 (4), p.295-306

2001

Volltextzugriff (PDF)

Unstable Preferences: A Shift in Valuation or an Effect of the Elicitation Procedure?

Medical decision making, 2000-01, Vol.20 (1), p.62-71

2000

Volltextzugriff (PDF)

Epithelial Ovarian Cancer: Rationale for Changing the One-Fits-All Standard Treatment Regimen to Subtype-Specific Treatment

International journal of gynecological cancer, 2014-03, Vol.24 (3), p.468-477

2014

Volltextzugriff (PDF)

The Effect of Individually Assessed Preference Weights on the Relationship between Holistic Utilities and Nonpreference-Based Assessment

Quality of life research, 2000-01, Vol.9 (5), p.541-557

2000

Volltextzugriff (PDF)

High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer

The New England journal of medicine, 2003-07, Vol.349 (1), p.7-16

2003

Volltextzugriff (PDF)

Fatigue and Relating Factors in High-Risk Breast Cancer Patients Treated With Adjuvant Standard or High-Dose Chemotherapy: A Longitudinal Study

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8296-8304

2005

Volltextzugriff (PDF)

Survival after recurrent osteosarcoma: Data from three European Osteosarcoma Intergroup (EOI) randomized controlled

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.10505-10505

2008

Volltextzugriff (PDF)

Molecular subtypes of breast cancer and amplification of topoisomerase II : predictive role in dose intensive adjuvant chemotherapy

British journal of cancer, 2006-11, Vol.95 (10), p.1334-1341

2006

Volltextzugriff (PDF)

Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: Update of the Dutch Randomized Trial

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.672-672

2005

Volltextzugriff (PDF)

1 – 25 von 203

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(176)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(122)
Life Sciences & Biomedicine
(117)
Humans
(89)
Female
(68)
Biological And Medical Sciences
(57)
Middle Aged
(47)
Oncology
(47)
Adult
(46)
Aged
(37)
Medical Sciences
(37)
Animals
(27)
Pharmacology. Drug Treatments
(27)
Chemotherapy
(26)
Male
(25)
Breast Neoplasms - Drug Therapy
(22)
Treatment Outcome
(22)
Fundamental And Applied Biological Sciences. Psychology
(20)
Tumors
(20)
Antineoplastic Agents
(19)
Aged, 80 And Over
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer

Molecular subtypes of breast cancer and amplification of topoisomerase IIα : predictive role in dose intensive adjuvant chemotherapy

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences

Response Shift in Quality of Life Measurement in Early-Stage Breast Cancer Patients Undergoing Radiotherapy

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?

Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study

Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer : is treatment worthwhile?

Survival of patients with ovarian cancer due to a mismatch repair defect

Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: A population-based study

Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

Diabetes insipidus and adrenal insufficiency in a patient with metastatic breast cancer

D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy

Stability of patients' preferences for chemotherapy: the impact of experience

Unstable Preferences: A Shift in Valuation or an Effect of the Elicitation Procedure?

Epithelial Ovarian Cancer: Rationale for Changing the One-Fits-All Standard Treatment Regimen to Subtype-Specific Treatment

The Effect of Individually Assessed Preference Weights on the Relationship between Holistic Utilities and Nonpreference-Based Assessment

High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer

Fatigue and Relating Factors in High-Risk Breast Cancer Patients Treated With Adjuvant Standard or High-Dose Chemotherapy: A Longitudinal Study

Survival after recurrent osteosarcoma: Data from three European Osteosarcoma Intergroup (EOI) randomized controlled

Molecular subtypes of breast cancer and amplification of topoisomerase II : predictive role in dose intensive adjuvant chemotherapy

Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: Update of the Dutch Randomized Trial

Suchergebnisse filtern